摘要
目的:在经典中医基础理论"肺开窍于鼻"指导下,按照肺鼻同治法原则自拟宣肺开窍汤,评价其治疗哮喘的疗效。方法:搜集符合纳入标准的哮喘合并过敏性鼻炎患者120例,随机分为3组,A组主要给予小剂量ICS联合宣肺开窍汤治疗;B组给予中等剂量ICS治疗;C组治疗方案为小剂量ICS联合三拗汤;治疗并随访时间为3个月,主要观察指标为评估哮喘控制情况、中医证候疗效、不良反应、ICS用量。结果:A、B组哮喘控制情况效果相当,但中医证候疗效A组较好,且副作用更低,ICS用量较小。C组较A、B组哮喘控制情况及中医证候疗效改善情况均较差。结论:"肺开窍于鼻"理论指导下的宣肺开窍汤,君、臣、佐、使诸药配伍,肺鼻同治,取宣肺平喘、化痰祛瘀、祛风开窍之效,针对哮喘病因病机根本发挥良效。由此,肺鼻同治在哮喘治疗中具有重要价值和作用,可进一步研究利用。
Objective:Under the guidance of basic theory of Fei Kaiqiao Yu Bi,we self-created the Xuanfei Kaiqiao decoction.The purpose of this study is to evaluate the efficacy of the decoction on asthma.Methods:120cases were randomly divided into3groups.Group A was given low dose ICS combined with the Xuanfei Kaiqiao decoction.Group B was given medium dose ICS.Group C was givenlow dose ICS combined with the San'ao decoction,for3months followed-up.Results:The effects of asthma control in group A and B wassimilar.Compared with group B,symptomatic characteristics of TCM in group A was better;the side effects was fewer;ICS dosage wassmaller.Asthma control and TCM syndrome improvement in group C were poorer than those in group A and group B.Conclusion:Underthe guidance of Fei Kaiqiao Yu Bi theory,and according to compatibility principles of TCM medicine,the Xuanfei Kaiqiao decoction wasmade;the decoction plays the roles of Xuanfei Pingchuan,Huatan Quyu,Qufeng Kaiqiao,for pathogenesis of asthma and gains a goodeffect.Thus,treating the disease from lung and nose at the same time showed important value,can be further study and utilization.
出处
《中医临床研究》
2017年第16期65-67,共3页
Clinical Journal Of Chinese Medicine
关键词
肺开窍于鼻
肺鼻同治
宣肺开窍汤
哮喘
Fei Kaiqiao Yu Bi
Treating disease from lung and nose at the same time
The Xuanfei Kaiqiao decoction
Asthma
